The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

The use of SSRIs for the treatment of depression and anxiety in young people is increasing. However, the effects of SSRIs in adolescence, a time when there are substantial changes in neural, cognitive, and social functioning, are not well understood. Here, we review evidence from clinical trials abo...

Полное описание

Библиографические подробности
Главные авторы:	Murphy, SE, Capitão, LP, Giles, SLC, Cowen, PJ, Stringaris, A, Harmer, CJ
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2021

Схожие документы

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
по: Harmer, C, и др.
Опубликовано: (2013)

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
по: Harmer, C, и др.
Опубликовано: (2013)

SSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression
по: Msetfi, RM, и др.
Опубликовано: (2016)

Neural response to implicit emotions as biomarkers of clinical response to SSRI treatment in depression
по: Godlewska, B, и др.
Опубликовано: (2017)

Acute neural effects of fluoxetine on emotional regulation in depressed adolescents
по: Capitão, LP, и др.
Опубликовано: (2022)

Does tryptophan supplementation induce similar changes in emotional processing to an SSRI?
по: Murphy, SE, и др.
Опубликовано: (2005)

Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns
по: Taquet, M, и др.
Опубликовано: (2021)

Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients
по: Godlewska, B, и др.
Опубликовано: (2011)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
по: Godlewska, B, и др.
Опубликовано: (2012)

Effect of the NMDA receptor partial agonist, d-cycloserine, on emotional processing and autobiographical memory
по: Chen, R, и др.
Опубликовано: (2020)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
по: Murphy, SE, и др.
Опубликовано: (2008)

Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration
по: Vai, B, и др.
Опубликовано: (2016)

Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.
по: Bhagwagar, Z, и др.
Опубликовано: (2004)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
по: Godlewska, B, и др.
Опубликовано: (2016)

SHORT-TERM SSRI TREATMENT REMEDIATES AMYGDALA HYPERACTIVITY IN DEPRESSED PATIENTS: A PLACEBO-CONTROLLED STUDY
по: Godlewska, B, и др.
Опубликовано: (2011)

Augmentation of SSRI treatment
по: Cowen, P
Опубликовано: (2008)

The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
по: Smith, ALW, и др.
Опубликовано: (2023)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
по: Murphy, S, и др.
Опубликовано: (2008)

Mechanisms of enhancer action: the known and the unknown
по: Anil Panigrahi, и др.
Опубликовано: (2021-04-01)

Acute SSRI administration affects the processing of social cues in healthy volunteers.
по: Harmer, C, и др.
Опубликовано: (2003)

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
по: Sharpley, A, и др.
Опубликовано: (2005)

The effect of the 5-HT4 agonist, Prucalopride, on a functional magnetic resonance imaging faces task in the healthy human brain
по: de Cates, AN, и др.
Опубликовано: (2022)

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
по: Colwell, MJ, и др.
Опубликовано: (2022)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex
по: McCabe, C, и др.
Опубликовано: (2011)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.
по: McCabe, C, и др.
Опубликовано: (2011)

Differences between SSRI and SNRI in depression treatment
по: Mateusz Grego, и др.
Опубликовано: (2025-01-01)

Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
по: de Cates, AN, и др.
Опубликовано: (2024)

The Known Into the Unknown
по: Antonio Sorgente, MD, PhD, и др.
Опубликовано: (2020-07-01)

The known and the unknown
по: Editorial
Опубликовано: (2010-01-01)

The known knowns and known unknowns of peacekeeping data
по: Dorussen, H, и др.
Опубликовано: (2016)

Anxiety increases breakthrough of threat stimuli in continuous flash suppression.
по: Capitão, L, и др.
Опубликовано: (2014)

Statins in depression: a repurposed medical treatment can provide novel insights in mental health
по: De Giorgi, R, и др.
Опубликовано: (2022)

Thyroid hormone action in adult neurogliogenic niches: the known and unknown
по: Victor Valcárcel-Hernández, и др.
Опубликовано: (2024-03-01)

Restless Legs Syndrome: Known Knowns and Known Unknowns
по: Elena Antelmi, и др.
Опубликовано: (2022-01-01)

Translating the promise of 5HT4 receptor agonists for the treatment of depression
по: Murphy, SE, и др.
Опубликовано: (2020)

SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
по: Quested, D, и др.
Опубликовано: (1997)

A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
по: Pulcu, E, и др.
Опубликовано: (2021)

Cardioneuroablation: the known and the unknown
по: A. Marrese, и др.
Опубликовано: (2024-07-01)

Vildagliptin: the known and unknown
по: L. Y. Morgunov
Опубликовано: (2016-12-01)

Anxiety increases breakthrough of threat stimuli in continuous flash suppression
по: Yang, E, и др.
Опубликовано: (2014)